
Media centre
Our media centre will help you to find information about AXA IM Alts long-term, global, investment manager.
Latest news
AXA IM Alts invests CHF 14m (€14.5m) into biotechnology company LimmaTech Biologics AG to develop next-generation vaccines
AXA IM Alts secures office prelet to SUEZ at Altiplano development in Paris La Défense
AXA IM Alts annonce la signature d’un bail avec SUEZ au sein d’Altiplano à Paris La Défense
AXA IM Alts secures approval and launches works for timber hybrid office development in Munich
- Load more news articles More articles will be added on the page when the button is clicked. The focus will be reassigned to the first new item